Open Heart

JANUARY 31, 2024

Background There is a paucity of data on the initiation patterns of anticoagulants among older atrial fibrillation patients with and without chronic kidney disease (CKD).

Kidney Disease 40

Kidney Disease Atrial Fibrillation Research 40

Journal of the American Heart Association

DECEMBER 24, 2024

BackgroundThis realworld evidence study compared risks of cardiovascular events in hospital settings among patients with chronic kidney disease (CKD) with and without hyperkalemia.Methods and ResultsAdults with CKD stages 3b/4 with and without hyperkalemia were identified from Optum's deidentified Market Clarity Data (January 2016August 2022).

Kidney Disease 45

Kidney Disease Arrhythmia Myocardial Infarction Atrial Fibrillation 45

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2024

Patients with atrial fibrillation (AF) taking antithrombotic (AT) therapy are at increased risk of gastrointestinal bleeding (GIB). Patients with atrial fibrillation (AF) taking antithrombotic (AT) therapy are at increased risk of gastrointestinal bleeding (GIB).

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Kidney Disease Stents 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 25, 2024

ABSTRACT Introduction Pulmonary vein isolation (PVI) by cryoballoon ablation (CBA) is considered an effective primary strategy for early persistent atrial fibrillation (AF). However, data regarding CBA for long-standing persistent AF (PeAF) are limited. years, 80% men) underwent de novo CBA. During a mean follow-up period of 15.110.9

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Kidney Disease 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 5, 2023

Abstract Introduction Influence of early atrial fibrillation (AF) ablation, particularly cryoballoon ablation (CBA), on clinical outcome during long-term follow-up has not been clarified. The primary outcome was recurrence of atrial tachyarrhythmias (ATs) of ≥30-s after a 3-month blanking period. vs. 31.7%, p  = 0.043).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Kidney Disease 40

DAIC

DECEMBER 8, 2023

Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).

Atrial Fibrillation 52

Atrial Fibrillation AFIB Strokes Stroke 52

Stroke Journal

JANUARY 30, 2025

Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrial fibrillation (AF) patients. Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH. Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025.

Atrial Fibrillation 40

Atrial Fibrillation Hemorrhage Risk Factors Kidney Disease 40

HeartRhythm

MAY 12, 2024

Left atrial appendage closure (LAAC) is an alternative to reduce thrombotic risk in patients with non-valvular atrial fibrillation. A significant proportion of patients who underwent this procedure have chronic kidney disease, presenting a high risk of contrast-induced nephropathy.

Kidney Disease 40

Kidney Disease Atrial Fibrillation 40

European Journal of Heart Failure

NOVEMBER 26, 2024

1.38), a diagnosis of atrial fibrillation (HR 1.24, 95% CI 1.10–1.39), 1.34), ischaemic heart disease (HR 1.20, 95% CI 1.09–1.31), Baseline characteristics independently associated with discontinuation were: estimated glomerular filtration rate (eGFR) <30 ml/min/1.73 m 2.27), hyperkalaemia (HR 1.73, 95% CI 1.25–2.40),

Heart Failure 71

Heart Failure Kidney Disease Atrial Fibrillation BMI 71

Journal of the American Heart Association

MARCH 27, 2025

Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovascular disease and smoking); (..)

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Open Heart

JUNE 1, 2022

Survival was higher among the younger patients, and among those with hypertension or atrial fibrillation (AF). Mortality was increased with male gender, valvular heart disease and chronic kidney disease. to 0.97; p=0.02).

Heart Failure 52

Heart Failure Kidney Disease Atrial Fibrillation Hypertension 52

Stroke Journal

JANUARY 30, 2025

Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.

Outcomes 40

Outcomes Atrial Fibrillation Heart Failure Tachycardia 40

Circulation

NOVEMBER 11, 2024

17.4]) and was also more likely to have diabetes mellitus, hyperlipidemia, chronic lung disease, chronic kidney disease, chronic liver disease, BMI ≥ 25, anemia, metastatic cancer, and atrial fibrillation. The hemophilia cohort was slightly older (63.2[16.8]

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

Circulation: Heart Failure

MARCH 8, 2024

The prevalence of HF risk factors was high: hypertension, 61.9%; former or current smoking, 53.7%; obesity 34.8%; diabetes; 24.7%; and chronic kidney disease; 22%. Overt cardiovascular disease, which ranged from 2.1% (HF) to 13.6% (atrial fibrillation), was less common.

Heart Failure 40

Heart Failure Atherosclerosis Kidney Disease Risk Factors 40

Stroke Journal

FEBRUARY 1, 2024

vs. 54.7%, SD 0.6), and had a lower burden of atrial fibrillation (4.5% vs. 6.9%, SD 0.1), chronic kidney disease (1.9% Patients with migraine were younger (40.2±15.2 standardized difference (SD) 0.38), more likely to be female (81.4% vs. 3.6%, SD 0.2), and congestive cardiac failure (2.7% vs. 5.1%, SD 0.12).

Strokes 40

Strokes Stroke Document Kidney Disease 40

Stroke Journal

FEBRUARY 1, 2024

vs 63.38, p&lt;0.001) and had fewer comorbidities such as cancer and chronic kidney disease, atrial fibrillation, hypertension, hyperlipidemia. We observed an increasing trend of ICH among pregnant individuals. Pregnant patients were notably younger (30.63 vs 16.2%, p&lt;0.001). vs 23.2%, p&lt;0.001).

Hemorrhage 40

Hemorrhage Outcomes Kidney Disease Atrial Fibrillation 40

Circulation

NOVEMBER 11, 2024

Logistic regression was used to analyze the relationship between the treatment groups and hospital readmission within 90 days.Results:Only 517 AA met inclusion criteria and did not meet exclusion criteria, which included a history of valvular heart disease, hypertrophic or restrictive cardiomyopathy, active myocarditis, history of cardiac arrest, and (..)

Heart Failure 40

Heart Failure Cardiac Arrest Kidney Disease Atrial Fibrillation 40

Circulation: Cardiovascular Quality & Outcomes

DECEMBER 6, 2023

had chronic kidney disease, and 60.6% had atrial fibrillation. We performed the least absolute shrinkage and selection operator logistic regression to predict escalation.Results:We included 437 hospitalizations; patients had a median age of 80 (interquartile range, 69–89) years, 58.1% were women, and 64.8% were White.

Heart Failure 40

Heart Failure Hospital Outcomes Inpatient 40

Frontiers in Cardiovascular Medicine

APRIL 7, 2025

In addition to direct hepatic complications, extra-hepatic complications, including cardiovascular diseases (CVD), type 2 diabetes (T2D), gastroesophageal reflux disease, chronic kidney disease and some malignancies, are increasingly recognized.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Kidney Disease Cardiovascular Disease 52

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

Open Heart

JULY 6, 2023

Background Chronic kidney disease (CKD) and atrial fibrillation (AF) are increasing in prevalence globally and share common risk factors. Our aim was to characterise real-world evidence on direct oral anticoagulant (DOAC) prescribing for people with AF and CKD, in terms of adherence, persistence and renal dose titration.

Kidney Disease 52

Kidney Disease Atrial Fibrillation Heart Failure Risk Factors 52

DAIC

SEPTEMBER 11, 2024

million Americans have atrial fibrillation. Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

All About Cardiovascular System and Disorders

OCTOBER 25, 2023

Rate vs Rhythm Control in Atrial Fibrillation Rate vs rhythm control as a management strategy in atrial fibrillation has been a long standing topic for debate. EAST-AFNET 4 trial had 2789 patients with early atrial fibrillation and cardiovascular conditions [8]. years of follow up per patient.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Ablation Cardiac Arrest 52

Open Heart

SEPTEMBER 14, 2022

Aims To describe the use of warfarin and direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) and chronic kidney disease (CKD), to evaluate changes in renal function over time and predictors of rapid decline, and to describe time in therapeutic range (TTR) and predictors of poor TTR among patients on warfarin.

Kidney Disease 52

Kidney Disease Atrial Fibrillation Heart Failure Diabetes 52

Open Heart

JANUARY 13, 2023

Objectives Accurate prediction of heart failure (HF) patients at high risk of atrial fibrillation (AF) represents a potentially valuable tool to inform shared decision making. No validated prediction model for AF in HF is currently available. The objective was to develop clinical prediction models for 1-year risk of AF.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Myocardial Infarction Kidney Disease 52

DAIC

SEPTEMBER 11, 2024

million Americans have atrial fibrillation. Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Stroke Journal

DECEMBER 8, 2023

BACKGROUND:Limited data exist on the temporal relationship between new-onset atrial fibrillation (AF) and ischemic stroke and its impact on patients’ clinical characteristics and mortality.METHODS:A population-based registry-linkage database includes all patients with new-onset AF in Finland from 2007 to 2018. Stroke, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Strokes Stroke Kidney Disease 40

DAIC

APRIL 9, 2024

Left untreated, tricuspid regurgitation can lead to atrial fibrillation , heart failure , kidney disease and even death. Current nonsurgical treatments include diuretics (medicines that help remove excess fluid and salt) and drugs aimed at easing symptoms. Rogers , professor of cardiovascular medicine.

Tricuspid 111

Tricuspid Heart Valves Bicuspid/Mitral Quality of Life 111

CardiacWire

OCTOBER 27, 2024

had no CKM syndrome risk factors, while 26% were at Stage 1 (overweight, prediabetes), 49% were Stage 2 (hypertension, diabetes, CKD), 5% had Stage 3 (kidney disease or high CVD risks), and 9% were Stage 4 (heart disease, with or without kidney disease). A JAMA analysis of 11k adults revealed that only 10.6%

AFIB 59

AFIB Hypertension Kidney Disease Heart Disease 59

Open Heart

JULY 10, 2023

Objective Risk-guided atrial fibrillation (AF) screening may be an opportunity to prevent adverse events in addition to stroke. We compared events rates for new diagnoses of cardio-renal-metabolic diseases and death in individuals identified at higher versus lower-predicted AF risk. to 6.98; 4.28), valvular heart disease (37.8;

Atrial Fibrillation 52

Atrial Fibrillation Myocardial Infarction Kidney Disease Innovation 52

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Below are some of the most notable highlights: 2024 ESC Updated Clinical Guidelines: Key updates include clopidogrel as a first-line option for long-term use after MI or PCI.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

In multivariate regression analysis, the factors independently associated with a greater risk of readmission within 90 days were hypercoagulation (1.359 [95%CI, 1.1274‐1.45]), opiod abuse and dependence (1.353 [95%CI, 1.238‐1.478]), chronic kidney disease (1.347 [95%CI, 1.316‐1.379]), liver disease (1.318 [95% CI, 1.26‐1.378]),

Risk Factors 40

Risk Factors Strokes Stroke Medicare 40

European Journal of Heart Failure

DECEMBER 1, 2023

Results Higher baseline PICP, PRO-C6 and PINP levels were associated with older age, a more severe HF presentation, higher levels of natriuretic peptides and high-sensitivity troponin T, and the presence of comorbid conditions such as chronic kidney disease and atrial fibrillation.

Heart Failure 40

Heart Failure Biomarkers Kidney Disease Atrial Fibrillation 40

Circulation

NOVEMBER 11, 2024

Predictors of high-risk of advanced liver fibrosis, included older age, male sex, severe chronic kidney disease, previous myocardial infarction, ischemic heart disease, and atrial fibrillation/flutter. High-risk of advanced liver fibrosis was highly prevalent, affecting 30% of the studied population.

Heart Failure 40

Heart Failure Diabetes Myocardial Infarction Kidney Disease 40

European Journal of Heart Failure

JANUARY 20, 2025

Recursive feature elimination was employed to identify the most relevant features in predicting the risk of mortality.

Heart Failure 40

Heart Failure Coronary Artery Disease Myocardial Infarction Kidney Disease 40

Stroke Journal

FEBRUARY 1, 2024

Characteristics associated with intracranial stent utilization were male sex, history of diabetes, hypertension, or chronic kidney disease, absence of atrial fibrillation or CHF, and southern US region. women; mean age, 69.1 [SD, years; mean NIHSS score of 15.1 [SD, years; mean NIHSS score of 13.8 [SD,

Stents 40

Stents Stent Strokes Stroke 40